Nancy Stroud, MD
Obstetrics & Gynecology · North Charleston, SCNPI 1053398420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $310 and has fallen 92.6% since, to $23 in 2025.
Across 67 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$207
- Organon$156
- Therapeuticsmd, Inc.$152
- Mayne Pharma Commercial LLC$93
- Duchesnay USA Incorporated$53
- Aspira Women's Health Inc$45
- plus $414 from 15 others
What the payments were for
- Food & beverage$1,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $207 |
| Organon | 7 | $156 |
| Therapeuticsmd, Inc. | 9 | $152 |
| Mayne Pharma Commercial LLC | 5 | $93 |
| Duchesnay USA Incorporated | 4 | $53 |
| Aspira Women's Health Inc | 2 | $45 |
| Novo Nordisk | 3 | $45 |
| Merck | 3 | $45 |
| Pfizer | 3 | $40 |
| Astellas Pharma US Inc | 2 | $38 |
| Exeltis, USA Inc. | 2 | $34 |
| Bayer | 2 | $29 |
| Amgen | 1 | $28 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Roche Diagnostics Corporation | 1 | $25 |
| Coopersurgical, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Optumhealth Care Solutions, LLC | 1 | $15 |
| Axonics, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$1,122 in reported general payments places this provider in the 60th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $2,351 |
| Estradiol (Twice Weekly)Estradiol | 28 | $1,661 |
| Zolpidem Tartrate | 16 | $91 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in North Charleston
- James MartinNorth Charleston$8K
- Christopher JenningsAnderson$1.3M
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
- Brooke NaffzigerWest Columbia$70K
- Judith BurgisColumbia$59K
- Charis ChambersGreenville$46K
- Angela ChoiCharleston$43K
- Andrew FuttermanCharleston$38K
- William OttingerCharleston$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.